HKD 20.15
(-0.98%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.01 Billion | 1.78 Billion | 3.12 Billion | 3.27 Billion | 2.72 Billion | 1.54 Billion |
Net Income | 3.03 Billion | 2.26 Billion | 3.05 Billion | 2.38 Billion | 1.75 Billion | 1.91 Billion |
Depreciation & Amortization | 391.39 Million | 360.87 Million | 325.75 Million | 315.68 Million | 297.49 Million | 258.22 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -301.63 Million | 199.56 Million | -430.86 Million | -1.15 Billion | 586.22 Million | 358.37 Million |
Other non-cash items | -1.11 Billion | -1.04 Billion | 177.22 Million | 1.73 Billion | 95.53 Million | -985.2 Million |
Investing Cash Flow | -701.95 Million | 171.3 Million | -2.26 Billion | -751.29 Million | -3.56 Billion | 45.73 Million |
Investments in PPE | -1.11 Billion | -1.46 Billion | -923.78 Million | -640.47 Million | -461.12 Million | -503.03 Million |
Acquisitions | -126.53 Million | -1.59 Billion | 29.2 Million | 93.91 Million | -515 Million | -52.82 Million |
Investment purchases | -6.07 Billion | -7.92 Billion | -10.25 Billion | -11.34 Billion | -10.81 Billion | -11.45 Billion |
Sales/Maturities of investments | 5.93 Billion | 9.52 Billion | 8.44 Billion | 11.24 Billion | 8.65 Billion | 12.11 Billion |
Other Investing Activities | 677.73 Million | 1.63 Billion | 436.43 Million | -110.81 Million | -436.64 Million | -65.61 Million |
Financing Cash Flow | 544.16 Million | -1.95 Billion | -1.01 Billion | -318.8 Million | -1.39 Billion | -853.63 Million |
Debt repayment | -1.31 Billion | -2.36 Billion | -607.54 Million | -870.57 Million | -845.75 Million | -1.21 Billion |
Dividends payments | -768.27 Million | -1.23 Billion | -1.87 Billion | -616.35 Million | -560.76 Million | -702.53 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.84 Million | 1.64 Billion | 466.17 Million | 1.16 Billion | 14.46 Million | 1.06 Billion |
Accounts receivables | -343.36 Million | 318.75 Million | -370.62 Million | -565.4 Million | 289.6 Million | 300.09 Million |
Accounts payables | 492.69 Million | -257.89 Million | -395.59 Million | -600.78 Million | -208.19 Million | - |
Inventory | -335.73 Million | -119.18 Million | -60.23 Million | -593.88 Million | 296.62 Million | 58.28 Million |
Other working capital | 377.46 Million | 257.89 Million | 395.59 Million | 600.78 Million | 208.19 Million | 43.68 Million |
Cash at beginning of period | 3.59 Billion | 3.59 Billion | 3.74 Billion | 1.53 Billion | 3.76 Billion | 3.02 Billion |
Cash at end of period | 5.44 Billion | 3.59 Billion | 3.59 Billion | 3.74 Billion | 1.53 Billion | 3.76 Billion |
Capital Expenditure | -1.11 Billion | -1.46 Billion | -923.78 Million | -640.47 Million | -461.12 Million | -503.03 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 1.85 Billion | -1.77 Million | -153.8 Million | 2.2 Billion | -2.23 Billion | 740.38 Million |
Free Cash Flow | 896.99 Million | 313.56 Million | 2.2 Billion | 2.63 Billion | 2.26 Billion | 1.04 Billion |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.52 Billion | 3.03 Billion | 1.26 Billion | 1.23 Billion | 2.26 Billion | 1.09 Billion |
Depreciation & Amortization | 215.52 Million | 391.39 Million | 182.83 Million | 208.55 Million | 360.87 Million | 170.74 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -301.63 Million | -599.15 Million | - | 199.56 Million | 193.12 Million |
Other non-cash items | -530.74 Million | -1.11 Billion | -111.74 Million | -159.42 Million | -1.04 Billion | -486.63 Million |
Investing Cash Flow | -2.68 Billion | -701.95 Million | -719.4 Million | 17.44 Million | 171.3 Million | 294.3 Million |
Investments in PPE | -583.81 Million | -1.11 Billion | -724.95 Million | -388.91 Million | -1.46 Billion | -851.36 Million |
Acquisitions | - | -126.53 Million | -57.48 Million | -46.67 Million | -1.59 Billion | - |
Investment purchases | - | -6.07 Billion | - | - | -7.92 Billion | - |
Sales/Maturities of investments | - | 5.93 Billion | - | - | 9.52 Billion | - |
Other Investing Activities | -2.09 Billion | 677.73 Million | 63.02 Million | 453.03 Million | 1.63 Billion | 1.14 Billion |
Financing Cash Flow | -1.58 Billion | 544.16 Million | -4.21 Million | 548.38 Million | -1.95 Billion | -785.15 Million |
Debt repayment | -630.74 Million | -1.31 Billion | - | -1.31 Billion | -2.36 Billion | - |
Dividends payments | -957.73 Million | -768.27 Million | - | -768.27 Million | -1.23 Billion | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -4.21 Million | 1.31 Billion | 1.64 Billion | -785.15 Million |
Accounts receivables | - | -343.36 Million | -343.36 Million | - | 318.75 Million | 318.75 Million |
Accounts payables | - | 492.69 Million | - | - | -257.89 Million | - |
Inventory | - | -335.73 Million | -335.73 Million | - | -119.18 Million | -119.18 Million |
Other working capital | - | 377.46 Million | 79.94 Million | - | 257.89 Million | -6.44 Million |
Cash at beginning of period | 5.44 Billion | 3.59 Billion | 5.43 Billion | - | 3.59 Billion | 3.11 Billion |
Cash at end of period | 2.37 Billion | 5.44 Billion | - | 5.43 Billion | 3.59 Billion | - |
Capital Expenditure | -583.81 Million | -1.11 Billion | -724.95 Million | -388.91 Million | -1.46 Billion | -851.36 Million |
Effect of forex changes on cash | - | - | -5.44 Billion | 3.59 Billion | - | -3.59 Billion |
Net cash flow / Change in cash | -3.06 Billion | 1.85 Billion | -5.43 Billion | 5.43 Billion | -1.77 Million | -3.11 Billion |
Free Cash Flow | 621.59 Million | 896.99 Million | 7.23 Million | 891.48 Million | 313.56 Million | 118.28 Million |
4491
GNTOF
8133
IFSPF
NOXOF
CHOLAFIN